Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium | Zendy

Eugenio Roberto Cosentino | Zendy; Daniela Degli Esposti | Zendy; Rinaldo Miceli | Zendy; Crescenzio Bentivenga | Zendy; Matteo Landolfo | Zendy; Ilaria Ricci Iamino | Zendy; Luca Spinardi | Zendy; G Magri | Zendy; Claudio Borghi | Zendy

Open Access

Coexisting Heart Failure and Chronic Obstructive Pulmonary Disease: Report of Two Cases Treated with Indacaterol/Glycopyrronium

Author(s) -

Eugenio Roberto Cosentino,

Daniela Degli Esposti,

Rinaldo Miceli,

Crescenzio Bentivenga,

Matteo Landolfo,

Ilaria Ricci Iamino,

Luca Spinardi,

G Magri,

Claudio Borghi

Publication year - 2018

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000487169

Subject(s) - indacaterol , medicine , copd , heart failure , concomitant , cardiology , pulmonary disease , comorbidity , asthma , bronchodilator

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, and it is associated with a high economic burden. Heart failure shares some general symptoms with COPD; thus, diagnosing COPD is difficult in subjects with a history of heart failure, and spi-rometry is mandatory for confirmation. Moreover, COPD is a highly prevalent comorbidity negatively impacting the outcome of heart failure patients. We document here the treatment with indacaterol/glycopyrronium in 2 patients with concomitant COPD and heart failure. Overall, the combination of indacaterol and glycopyrronium resulted in a reciprocal potentiation with a maximal bronchodilatory effect.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research